期刊文献+

急性肺血栓栓塞患者血浆对内皮细胞eNOS及HSP90表达的影响 被引量:1

Effect of PTE patients blood plasm on the protein expression of eNOS and HSP90 in endothelial cells
暂未订购
导出
摘要 目的探讨急性肺血栓栓塞(PTE)患者血浆刺激血管内皮细胞对eNOS及HSP90表达的影响,进一步了解NO产生的机制。方法分别用正常人血浆和PTE患者血浆刺激人脐静脉血管内皮细胞(HUVEC),哥尔德霉素(Geldanamycin)抑制HSP90的作用后,以硝酸还原酶法测定各组细胞培养上清NO浓度,免疫组织化学法测定脐静脉内皮细胞eNOS及HSP90表达水平。结果加入PTE患者血浆处理HUVEC组eNOS及HSP90表达水平较加入正常人血浆处理组增强;PTE患者血浆处理HUVEC组NO浓度为(16.62±3.14)μmol/L,正常人血浆处理组NO浓度为(5.16±1.98)μmol/L,经统计学分析两组差异有统计学意义(t=13.2,P<0.05)。哥尔德霉素处理组NO浓度为(9.34±1.09)μmol/L,明显低于PTE患者血浆处理组,差异有统计学意义(t=15.6,P<0.05)。结论PTE患者血浆可以刺激血管内皮细胞eNOS及HSP90表达上调;HSP90的抑制剂哥尔德霉素可以通过抑制HSP90从而下调NO的产生。 Objective To explore the effect of PTE patients blood plasm on the protein expression of eNOS and HSP90 in endothelial cells and the mechanism of produce nitric oxide ( NO). Methods Human umbilical vein endothelial cells were cultured with PIE patients blood plasm( experiment group) and normal people blood plasm (control group), the NO concentration in cultured cell supernatant were detenninned with nitrate reductase method, The expression of HSP90 and eNOS protein were detected by immunocytochemistry, the NO production was also measured after using Geldanamycin to block the action of HSP90. Results The expression of HSP90 and eNOS protein in experiment group were higher than that in control group; the NO concentration [ ( 16.62 ± 3.14)μmol/L] in experiment group was significantly higher than that in control group [(5.16 ± 1.98 )μmol/L], (t = 13.2, P 〈 0. 05) , the NO concentration in the Geldanamycin treated group was 9.34 ± 1.09μmol/L, compared with the experiment group, the distinction was obvious( t = 15.6, P 〈 0. 05). Conclusion PIE patients blood plasm can up- regulate the expression of eNOS and HSP90 protein in endothelial cell, Blocking the role of HSP90 can reduce production of NO.
出处 《中国急救医学》 CAS CSCD 北大核心 2006年第6期401-403,共3页 Chinese Journal of Critical Care Medicine
基金 国家自然科学基金资助项目(No.50347009)
  • 相关文献

参考文献7

  • 1温绍君,张维君,房芳.肺栓塞的病理生理[J].中华心血管病杂志,2001,29(5):259-260. 被引量:53
  • 2Fleming I, Bauersachs J, Fisslthaler B, et al . Ca^2+ - independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress[J]. Circ Res, 1998, 82(6) :686- 695.
  • 3Garcia- Cardena G, Fan R, Shah V, et al, Dynamic activation of endothelial nitric oxide synthase by Hsp90 [ J]. Nature, 1998, 392(6678) : 821 - 824.
  • 4Koedel U, Paul R, Winkler F, et al. Lack of endothelial nitric oxide synthase aggravates mnrine pneumococcal meningitis [ J ]. J Neuropathol Exp Neurol, 2001, 60(11):1041 - 1050.
  • 5Trummer G, Berchtold- Hers M, Martin J , et al. Successful treatment of pulmonary hypertension with inhaled nitric oxide after pulmonary embolectomy [J]. Ann Thorac Surg, 2002, 73(4): 1299-1301.
  • 6Tanus - Santos JE, Moreno H. Is there a place for inhaled nitric oxide in the therapy of massive pulmonary embolism[J]? Anesthesiology, 2001,94(2) :354.
  • 7Whitesell L, Mimnaugh EG, De Costa B, et al. Inhibition of heat shock protein HSP90- pp60v- src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oneogenic transformation[J]. Proc Natl Acad Sci USA, 1994,91:8324-8328.

二级参考文献4

共引文献52

同被引文献33

  • 1张建初,杨卫兵,张晓菊,夏蕾,陶晓南,白明.热休克蛋白90在急性肺栓塞患者血浆刺激内皮细胞一氧化氮表达中的作用[J].中华急诊医学杂志,2007,16(2):185-188. 被引量:1
  • 2郭丹杰,胡大一.美国临床肿瘤学会癌症患者静脉血栓栓塞防治指南解读[C].第十届中国南方国际心血管病学术会议论文集,2008:550-553.
  • 3王洋,杨媛华.手术与静脉血栓栓塞症[J].中国医刊,2008,43(1):10-12. 被引量:14
  • 4Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality [J]. Thromb Haemost, 2007, 98 (4): 756-764.
  • 5Smith NL, Rice KM, Bovill EG, et al. Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thromhosis[J]. Blood, 2011,117 (22) : 6007-6011.
  • 6Goldhaber SZ. Risk factors for venous thromboembolism[J]. J Am Coil Cardiol, 2010, 56 (1) : 1-7.
  • 7Urrutia RP, Coeytaux RR, Mebroom AJ, et al. Risk of acute thromboembolie events with oral contraceptive use a systematic review and meta-analysis [J]. Obstet Gyneeol, 2013, 122 (2 Pt 1): 380-389.
  • 8Matos MF, Lourenco DM, Orikaza CM, et al. Abdominal obesity and the risk of venous thromboembolism among women: a potential role of interleukin-6 [J]. Metab Syndr Relat Disord,2013, 11 (1) : 29-34.
  • 9Bonnar J. Can more be done in obstetric and gynecologic practice to reduce morbidity and mortality associated withvenous thromboembolism? [J]. Am J Obstet Gynecol, 1999,180(4) :784-791.
  • 10Zhang G, Xu X, Su W, et al. Smoking and risk of venous thromboembolism:a systematic review[J]. Southeast Asian J Trop Med Public Health, 2014,45 (3) : 736-745.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部